A Phase 2, Dose-Finding, Cross-Over Study to Evaluate the Effect of a NES/E2 Transdermal Gel Delivery on Ovulation Suppression in Normal Ovulating Women
Phase of Trial: Phase II
Latest Information Update: 29 May 2015
At a glance
- Drugs Estradiol/elcometrine (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- 16 Apr 2015 Planned End Date changed from 1 Jun 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov record.
- 16 Apr 2015 Planned primary completion date changed from 1 Jun 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov record.
- 16 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History